Analytical Challenges for Biological Drug Substances and Products - This conference is part of PharmaLab 2019
Programme
Regulatory Requirements of analytical procedure & validation
Dr Norbert Handler, RD &C Research, Development & Consulting
How to overcome some of the challenges when analysing Biological Drug Substances and Products
Thomas Fechner, Agilent
Analytical Quality by Design Through the Lifecycle
Patrick Jackson, GSK
State-of-the-Art evaluation of potency bioassays
Klemens Weitenthaler, VelaLabs - A Tentamus Company
Process for automatization of a Bioassay
Dr Marcus Gutmann, Microcoat Biotechnologie
Application of fast and non-destructive analysis techniques in quality and in-process control
Prof. Dr. Hartwig Schulz, formerly Julius Kühn-Institut (JKI)
Lectin Array – a novel technology for investigation of pharmaceutical products
Markus Roucka, VelaLabs - A Tentamus Company
This event is currently unavailable. Visit the full overview for live events and recordings, or contact our team directly via the contact form.
not available
not available
Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org
Testimonials
